Security key
71722W107
Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)
CUSIP: 71722W107
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 43,760,270
- Total 13F value
- $452,721,621
- Share change
- +982,744
- Put/Call ratio
- 30%
- SEC-reported price per share
- $10.37
- Number of holders
- 109
- Value change
- +$5,267,236
- Number of buys
- 63
- Number of sells
- 30
- Shares outstanding
- 79,611,764
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
109
Top holders
10
PHAT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Phathom Pharmaceuticals, Inc. SEC filings
Phathom Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71722W107
Recent filing periods:
Ownership snapshot
Top reported holders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Frazier Life Sciences Man...
Disclosed value leader
Frazier Life Sciences Man...
Comparable rows
0/15
Latest evidence
30 Jun 2023
13F
Highest disclosed value: $144,764,875
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Frazier Life Sciences Management, L.P. has the largest disclosed position value at $144.76M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Frazier Life Sciences Management, L.P.'s linked filing trail.
Disclosed position value
Top 5
Frazier Life Sciences Management,...
$144.76M
Medicxi Ventures Management (Jers...
$53.86M
Carlyle Group Inc.
$50.07M
Invesco Ltd.
$47.72M
BlackRock Finance, Inc.
$28.68M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
Company
|
—
denominator unverified
|
$144,764,875
10,109,279 shares
|
— | 30 Jun 2023 |
| Medicxi Ventures Management (Jersey) Ltd |
13F
Company
|
—
denominator unverified
|
$53,855,644
3,760,869 shares
|
— | 30 Jun 2023 |
| Carlyle Group Inc. |
13F
Company
|
—
denominator unverified
|
$50,074,291
3,496,808 shares
|
— | 30 Jun 2023 |
| Invesco Ltd. |
13F
Company
|
—
denominator unverified
|
$47,716,202
3,332,137 shares
|
— | 30 Jun 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$28,677,691
2,002,632 shares
|
— | 30 Jun 2023 |
| Avidity Partners Management LP |
13F
Company
|
—
denominator unverified
|
$27,919,704
1,949,700 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
109
Shares
43,760,270
Rows available
109
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
103
Q3 2023 holders
109
Holder diff
6
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend